NCT03309813 - Feasibility Study of ExAblate Thalamotomy for Treatment of Chronic Trigeminal Neuropathic Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions

Trigeminal Neuropathic Pain

Interventions

DEVICE

Transcranial ExAblate

ExAblate Thalamotomy for Chronic Trigeminal Neuropathic Pain

DEVICE

Sham Transcranial ExAblate

Sham ExAblate Thalamotomy procedure

DEVICE

Crossover Transcranial Exablate

Subjects randomized to the Sham Exablate could opt for the Crossovover Transcranial Exablate Arm (Exablate Thalamotomy) after completing the Month 3 visit in the Sham Arm.

Trial Locations (1)

22908

University of Virginia, Charlottesville